← Eichor
Condition: Elevated Lipoprotein A Level Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Elevated Lipoprotein A Level

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemi
Phase 2 · 34 location(s) · Regeneron Pharmaceuticals · NCT07477704Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Phase 2 · 59 location(s) · Kylonova (Xiamen) Biopharma co., LTD. · NCT0732784024 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT06014060Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Ident
Phase N/A · 1 location(s) · E.S.stroes · NCT06995183A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Ev
Phase 3 · 58 location(s) · Eli Lilly and Company · NCT07613294Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Phase 3 · 40 location(s) · Amgen · NCT07293260A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
Phase 2 · 12 location(s) · Merck Sharp & Dohme LLC · NCT07614984A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
Phase 1/Phase 2 · 1 location(s) · Sirius Therapeutics Co., Ltd. · NCT07172646A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Particip
Phase 1 · 6 location(s) · AstraZeneca · NCT06980428AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
Phase N/A · 1 location(s) · University of Galway · NCT07577609Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
NA · 2 location(s) · Odense University Hospital · NCT05614219Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · 772 location(s) · Eli Lilly and Company · NCT07157774Lipid Screening Study
Phase N/A · 1 location(s) · University of Central Florida · NCT07579325OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · 249 location(s) · Amgen · NCT07136012Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterole
Phase 3 · 19 location(s) · Novartis Pharmaceuticals · NCT06597006Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Phase 3 · 66 location(s) · Novartis Pharmaceuticals · NCT06597019Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · 95 location(s) · Novartis Pharmaceuticals · NCT06813911
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.